• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征伴胰岛素抵抗患者的肠道微生物组成:来自正常体重人群的研究结果。

The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.

机构信息

Department of Assisted Reproduction, Xiangya Hospital, Central South University, 410008, Changsha, People's Republic of China.

出版信息

J Ovarian Res. 2021 Mar 27;14(1):50. doi: 10.1186/s13048-021-00799-9.

DOI:10.1186/s13048-021-00799-9
PMID:33773586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8005233/
Abstract

BACKGROUND

Limited studies have reported the relationship between intestinal flora dysbiosis and clinical characteristics in polycystic ovary syndrome (PCOS). However, the structure and characteristics of gut microbiota in PCOS have not been fully elucidated.

OBJECTIVE

To analyze the composition of the Intestinal flora population in normal-weight women with PCOS and insulin resistance(IR) compared to PCOS alone and healthy women.

METHODS

A total of 14 PCOS patients with insulin resistant(PCOS-IR) and 12 PCOS alone (PCOS-NIR), and 10 age- and body mass index-matched healthy control women (HC). BMI: 18.5-23.9 kg/m. The bacterial 16 S rDNA V3-V4 fragment was amplified and sequenced. Then, the sequencing data were analyzed for species annotation, community diversity, and inter-group differences, to explore gut microbial characteristics of the subjects and their correlation with clinical parameters.

RESULTS

No significant difference in diversity was observed between PCOA and sample cluster analysis among the three groups (Beta-diversity) and Alpha-diversity. The relative abundance of Rothia, Ruminococcus, and Enterococcus was significantly higher in the PCOS-IR group than in the other two groups (P < 0.05), while that of Prevotella was dramatically decreased (P < 0.05). The abundance of Enterococcus was positively correlated with waist circumference, hip circumference, diastolic blood pressure, and insulin resistance index. Meanwhile, Rothia abundance is positively associated with waist circumference and free fatty acids.

CONCLUSIONS

The gut microbial composition of PCOS patients with insulin resistance is different from that of PCOS alone and healthy women. The difference is correlated with the clinical characteristics of PCOS, with regards to insulin resistance, abdominal obesity, free fatty acids, and other indicators. PCOS-IR patients have an increased abundance of Enterococcus which potentially the intestinal environment of the host by enriching the metabolic pathways related to insulin resistance, causing the occurrence and development of PCOS.

摘要

背景

有限的研究报告了肠道菌群失调与多囊卵巢综合征(PCOS)临床特征之间的关系。然而,PCOS 中肠道微生物群的结构和特征尚未完全阐明。

目的

分析与单纯 PCOS 相比,伴有胰岛素抵抗(IR)的正常体重 PCOS 妇女肠道菌群的组成。

方法

共纳入 14 例胰岛素抵抗的 PCOS 患者(PCOS-IR)、12 例单纯 PCOS 患者(PCOS-NIR)和 10 例年龄和体重指数匹配的健康对照妇女(HC)。BMI:18.5-23.9kg/m。扩增和测序细菌 16S rDNA V3-V4 片段。然后,对测序数据进行物种注释、群落多样性和组间差异分析,以探讨研究对象的肠道微生物特征及其与临床参数的相关性。

结果

三组间(β多样性)和 Alpha 多样性无明显差异。与其他两组相比,PCOS-IR 组中 Rothia、Ruminococcus 和 Enterococcus 的相对丰度显著升高(P<0.05),而 Prevotella 的相对丰度显著降低(P<0.05)。Enterococcus 的丰度与腰围、臀围、舒张压和胰岛素抵抗指数呈正相关。同时,Rothia 的丰度与腰围和游离脂肪酸呈正相关。

结论

伴胰岛素抵抗的 PCOS 患者的肠道微生物组成与单纯 PCOS 患者和健康女性不同。这种差异与 PCOS 患者的临床特征有关,包括胰岛素抵抗、腹型肥胖、游离脂肪酸等指标。PCOS-IR 患者的 Enterococcus 丰度增加,可能通过丰富与胰岛素抵抗相关的代谢途径,使宿主肠道环境发生变化,导致 PCOS 的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/b8e89667abc4/13048_2021_799_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/545843ca8779/13048_2021_799_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/d6591f3d9889/13048_2021_799_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/b7d4940ec6b9/13048_2021_799_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/0c998a3d9484/13048_2021_799_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/79097470e2ef/13048_2021_799_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/b8e89667abc4/13048_2021_799_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/545843ca8779/13048_2021_799_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/d6591f3d9889/13048_2021_799_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/b7d4940ec6b9/13048_2021_799_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/0c998a3d9484/13048_2021_799_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/79097470e2ef/13048_2021_799_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c1f/8005233/b8e89667abc4/13048_2021_799_Fig6_HTML.jpg

相似文献

1
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.多囊卵巢综合征伴胰岛素抵抗患者的肠道微生物组成:来自正常体重人群的研究结果。
J Ovarian Res. 2021 Mar 27;14(1):50. doi: 10.1186/s13048-021-00799-9.
2
Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.多囊卵巢综合征伴胰岛素抵抗(IR-PCOS)患者肠道微生物群落的结构和功能特征:一项初步研究。
Res Microbiol. 2019 Jan-Feb;170(1):43-52. doi: 10.1016/j.resmic.2018.09.002. Epub 2018 Oct 4.
3
Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report.多囊卵巢综合征中的肠道菌群失调:与肥胖的关联——初步报告。
Can J Physiol Pharmacol. 2020 Nov;98(11):803-809. doi: 10.1139/cjpp-2019-0413. Epub 2020 Mar 9.
4
Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.评价艾灸治疗多囊卵巢综合征的潜力:基于肠道微生物群和代谢物相互作用的大鼠模型研究。
Front Cell Infect Microbiol. 2024 Apr 11;14:1328741. doi: 10.3389/fcimb.2024.1328741. eCollection 2024.
5
16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.多囊卵巢综合征肠道微生物群的16S rDNA全长组装测序技术分析
Front Cell Infect Microbiol. 2021 May 10;11:634981. doi: 10.3389/fcimb.2021.634981. eCollection 2021.
6
Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.多囊卵巢综合征伴血脂异常患者的肠道微生物特征。
BMC Microbiol. 2024 May 17;24(1):169. doi: 10.1186/s12866-024-03329-x.
7
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.肠道微生物群对多囊卵巢综合征小鼠中 omega-3 介导的卵巢和代谢益处的影响。
J Ovarian Res. 2023 Jul 14;16(1):138. doi: 10.1186/s13048-023-01227-w.
8
A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.多囊卵巢综合征的新方法:肠道微生物群。
J Am Coll Nutr. 2020 May-Jun;39(4):371-382. doi: 10.1080/07315724.2019.1657515. Epub 2019 Sep 12.
9
Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?多囊卵巢综合征中的血脂异常:不同群体,不同病因?
Hum Reprod. 1996 Sep;11(9):1848-53. doi: 10.1093/oxfordjournals.humrep.a019505.
10
Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征患者肠道微生物组成的扰动:系统评价和荟萃分析。
BMC Med. 2023 Aug 9;21(1):302. doi: 10.1186/s12916-023-02975-8.

引用本文的文献

1
Mechanisms of traditional Chinese medicine regulating polycystic ovary syndrome through gut microbiota: a review.中药通过肠道微生物群调节多囊卵巢综合征的机制:综述
Front Endocrinol (Lausanne). 2025 Aug 6;16:1610869. doi: 10.3389/fendo.2025.1610869. eCollection 2025.
2
Huatan Tongmai Yin regulates RFRP-3 to intervene in the "microbe-gut-HPO axis" to treat PCOS-IR rats.化痰通脉饮通过调节RFRP-3干预“微生物-肠道-下丘脑-垂体-卵巢轴”来治疗多囊卵巢综合征-胰岛素抵抗大鼠。
Am J Transl Res. 2025 Jul 15;17(7):4879-4893. doi: 10.62347/XGFS9323. eCollection 2025.
3
Metabolic disorders in polycystic ovary syndrome: from gut microbiota biodiversity to clinical intervention.

本文引用的文献

1
The Characterization of Genus: Resistance Mechanisms and Inflammatory Bowel Disease.属的特征:耐药机制与炎症性肠病
Open Med (Wars). 2020 Apr 3;15:211-224. doi: 10.1515/med-2020-0032. eCollection 2020.
2
Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review.肠道微生物群与多囊卵巢综合征(PCOS)关系的探讨:综述
Geburtshilfe Frauenheilkd. 2020 Feb;80(2):161-171. doi: 10.1055/a-1081-2036. Epub 2020 Feb 21.
3
Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE.
多囊卵巢综合征中的代谢紊乱:从肠道微生物群生物多样性到临床干预
Front Endocrinol (Lausanne). 2025 Apr 28;16:1526468. doi: 10.3389/fendo.2025.1526468. eCollection 2025.
4
Gut microbiota: a hidden player in polycystic ovary syndrome.肠道微生物群:多囊卵巢综合征中一个隐藏的参与者。
J Transl Med. 2025 Apr 15;23(1):443. doi: 10.1186/s12967-025-06315-7.
5
Unraveling the gut microbiota's role in PCOS: a new frontier in metabolic health.揭示肠道微生物群在多囊卵巢综合征中的作用:代谢健康的新前沿。
Front Endocrinol (Lausanne). 2025 Mar 18;16:1529703. doi: 10.3389/fendo.2025.1529703. eCollection 2025.
6
Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012-2023).多囊卵巢综合征肠道微生物群的研究热点与趋势:一项文献计量分析(2012 - 2023年)
Front Microbiol. 2025 Jan 8;15:1524521. doi: 10.3389/fmicb.2024.1524521. eCollection 2024.
7
Gut Microbiota and Oral Contraceptive Use in Women with Polycystic Ovary Syndrome: A Systematic Review.肠道微生物群与多囊卵巢综合征女性使用口服避孕药:系统评价。
Nutrients. 2024 Oct 4;16(19):3382. doi: 10.3390/nu16193382.
8
The gut microbiota: emerging biomarkers and potential treatments for infertility-related diseases.肠道微生物群:不孕相关疾病的新兴生物标志物和潜在治疗方法。
Front Cell Infect Microbiol. 2024 Sep 26;14:1450310. doi: 10.3389/fcimb.2024.1450310. eCollection 2024.
9
Gut and oral microbiota in gynecological cancers: interaction, mechanism, and therapeutic value.妇科恶性肿瘤的肠道和口腔微生物群:相互作用、机制和治疗价值。
NPJ Biofilms Microbiomes. 2024 Oct 10;10(1):104. doi: 10.1038/s41522-024-00577-7.
10
Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.多囊卵巢综合征伴血脂异常患者的肠道微生物特征。
BMC Microbiol. 2024 May 17;24(1):169. doi: 10.1186/s12866-024-03329-x.
肠球菌金属蛋白酶 GelE 降解肠降血糖素激素胰高血糖素样肽-1(GLP-1)。
mSphere. 2020 Feb 12;5(1):e00585-19. doi: 10.1128/mSphere.00585-19.
4
Shifts in the bacterial community of saliva give insights on the relationship between obesity and oral microbiota in adolescents.唾液细菌群落的变化揭示了肥胖与青少年口腔微生物群之间的关系。
Arch Microbiol. 2020 Jul;202(5):1085-1095. doi: 10.1007/s00203-020-01817-y. Epub 2020 Feb 7.
5
Is copeptin a new potential biomarker of insulin resistance in polycystic ovary syndrome?copeptin是多囊卵巢综合征中胰岛素抵抗的一种新的潜在生物标志物吗?
Ginekol Pol. 2019;90(3):115-121. doi: 10.5603/GP.2019.0021.
6
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.多囊卵巢综合征不同表型之间胰岛素抵抗的差异
Expert Rev Endocrinol Metab. 2013 Sep;8(5):427-429. doi: 10.1586/17446651.2013.827373.
7
Sex, Microbes, and Polycystic Ovary Syndrome.性别、微生物与多囊卵巢综合征。
Trends Endocrinol Metab. 2019 Jan;30(1):54-65. doi: 10.1016/j.tem.2018.11.001. Epub 2018 Nov 29.
8
Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.多囊卵巢综合征伴胰岛素抵抗(IR-PCOS)患者肠道微生物群落的结构和功能特征:一项初步研究。
Res Microbiol. 2019 Jan-Feb;170(1):43-52. doi: 10.1016/j.resmic.2018.09.002. Epub 2018 Oct 4.
9
Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity.肠道微生物群与多囊卵巢综合征:性别、性激素和肥胖的影响。
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2552-2562. doi: 10.1210/jc.2017-02799.
10
Best practices for analysing microbiomes.微生物组分析的最佳实践。
Nat Rev Microbiol. 2018 Jul;16(7):410-422. doi: 10.1038/s41579-018-0029-9.